These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31988096)

  • 1. Lychnopholide in Poly(d,l-Lactide)-
    Branquinho RT; de Mello CGC; Oliveira MT; Reis LES; Vieira PMA; Saúde-Guimarães DA; Mosqueira VCF; de Lana M
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Lychnopholide Polymeric Nanocapsules after Oral and Intravenous Administration in Murine Experimental Chagas Disease.
    de Mello CG; Branquinho RT; Oliveira MT; Milagre MM; Saúde-Guimarães DA; Mosqueira VC; Lana Md
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5215-22. PubMed ID: 27324760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sesquiterpene lactone in nanostructured parenteral dosage form is efficacious in experimental Chagas disease.
    Branquinho RT; Mosqueira VC; de Oliveira-Silva JC; Simões-Silva MR; Saúde-Guimarães DA; de Lana M
    Antimicrob Agents Chemother; 2014; 58(4):2067-75. PubMed ID: 24449777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lychnopholide loaded in surface modified polylactide nanocapsules (LYC-PLA-PEG-NC) cure mice infected by Trypanosoma cruzi strain a prototype of resistance to benznidazole and nifurtimox: First insights of its mechanism of action.
    Milagre MM; Torchelsen FKVDS; Pedrosa TCF; Teixeira GM; Sampaio LS; Saúde-Guimarães DA; Branquinho RT; Mosqueira VCF; Lana M
    Exp Parasitol; 2023 Dec; 255():108647. PubMed ID: 37914151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Body Exposure to New Anti-Trypanosomal Through Nanoencapsulation.
    Tupinambá Branquinho R; Pound-Lana G; Marques Milagre M; Saúde-Guimarães DA; Vilela JMC; Spangler Andrade M; de Lana M; Mosqueira VCF
    Sci Rep; 2017 Aug; 7(1):8429. PubMed ID: 28814794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benznidazole, itraconazole and their combination in the treatment of acute experimental chagas disease in dogs.
    Cunha ELA; Torchelsen FKVDS; Cunha LM; de Oliveira MT; Fonseca KDS; Vieira PMA; Carneiro CM; de Lana M
    Exp Parasitol; 2019 Sep; 204():107711. PubMed ID: 31254494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro interaction of polyethylene glycol-block-poly(D,L-lactide) nanocapsule devices with host cardiomyoblasts and Trypanosoma cruzi-infective forms.
    Siqueira RP; Milagre MM; de Oliveira MA; Branquinho RT; Torchelsen FKV; de Lana M; Machado MGC; Andrade MS; Bahia MT; Mosqueira VCF
    Parasitol Res; 2022 Oct; 121(10):2861-2874. PubMed ID: 35972545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable Polymeric Nanocapsules Prevent Cardiotoxicity of Anti-Trypanosomal Lychnopholide.
    Branquinho RT; Roy J; Farah C; Garcia GM; Aimond F; Le Guennec JY; Saude-Guimarães DA; Grabe-Guimaraes A; Mosqueira VC; de Lana M; Richard S
    Sci Rep; 2017 Mar; 7():44998. PubMed ID: 28349937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicines against Chagas disease: an update on therapeutics, prophylaxis and diagnosis.
    Morilla MJ; Romero EL
    Nanomedicine (Lond); 2015 Feb; 10(3):465-81. PubMed ID: 25707979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of the sesquiterpene lactone goyazensolide against
    Milagre MM; Branquinho RT; Gonçalves MF; de Assis G; de Oliveira MT; Reis L; Saúde-Guimarães DA; de Lana M
    Parasitology; 2020 Jan; 147(1):108-119. PubMed ID: 31455451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunomodulatory effects of the Enalapril in combination with Benznidazole during acute and chronic phases of the experimental infection with Trypanosoma cruzi.
    Leite ALJ; Paula Costa G; Lopes LR; Reis Mota LWD; Vieira PMA; Talvani A
    Acta Trop; 2017 Oct; 174():136-145. PubMed ID: 28720491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
    Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.
    Torchelsen FKVDS; Silva TM; Milagre MM; Silva RR; Reis LES; Branquinho RT; Silva GN; de Lana M
    Parasitol Res; 2021 Apr; 120(4):1511-1517. PubMed ID: 33236174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cure of experimental Chagas' disease by the bis-triazole DO870 incorporated into 'stealth' polyethyleneglycol-polylactide nanospheres.
    Molina J; Urbina J; Gref R; Brener Z; Rodrigues Júnior JM
    J Antimicrob Chemother; 2001 Jan; 47(1):101-4. PubMed ID: 11152439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts.
    Molina J; Martins-Filho O; Brener Z; Romanha AJ; Loebenberg D; Urbina JA
    Antimicrob Agents Chemother; 2000 Jan; 44(1):150-5. PubMed ID: 10602737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with benznidazole and doxycycline shows no additive effect to monotherapy with benznidazole in mice infected with the VL-10 strain of the Trypanosoma cruzi.
    Carneiro ACA; Costa GP; Ferreira CS; Ramos IPR; Sarandy MM; Leite ALJ; Menezes APJ; Silva BM; Nogueira KOPC; Carvalho ACC; Gonçalves RV; Talvani A
    Int J Cardiol; 2020 Jan; 299():243-248. PubMed ID: 31353153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.
    Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV.
    Zanusso Junior G; Massago M; Kian D; Toledo MJO
    Exp Parasitol; 2018 Feb; 185():92-97. PubMed ID: 29305891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time and dose-dependence evaluation of nitroheterocyclic drugs for improving efficacy following Trypanosoma cruzi infection: A pre-clinical study.
    Mazzeti AL; Diniz LF; Gonçalves KR; Nascimento AFS; Spósito PAF; Mosqueira VCF; Machado-Coelho GLL; Ribeiro I; Bahia MT
    Biochem Pharmacol; 2018 Feb; 148():213-221. PubMed ID: 29309767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi.
    Michailowsky V; Murta SM; Carvalho-Oliveira L; Pereira ME; Ferreira LR; Brener Z; Romanha AJ; Gazzinelli RT
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2549-56. PubMed ID: 9756754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.